Pharmaceutical policies and regulations of oral antiviral drugs for treatment of hepatitis C in Egypt—case study

被引:0
|
作者
Mahmoud H. Teaima
Adi Al-Nuseirat
Dalia Abouhussein
Osama A. Badary
Mohamed A. El-Nabarawi
机构
[1] Cairo University,Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy
[2] World Health Organization Office for the Eastern Mediterranean Region,Access to Medicines and Health Technologies Unit
[3] Egyptian Drug Authority (EDA),Pharmaceutics Department
[4] The British University in Egypt,Department of Clinical Pharmacy Practice, Faculty of Pharmacy
关键词
Pharmaceutical regulations; Direct-acting antivirals; Hepatitis C virus;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Pharmaceutical policies and regulations of oral antiviral drugs for treatment of hepatitis C in Egypt-case study
    Teaima, Mahmoud H.
    Al-Nuseirat, Adi
    Abouhussein, Dalia
    Badary, Osama A.
    El-Nabarawi, Mohamed A.
    JOURNAL OF PHARMACEUTICAL POLICY AND PRACTICE, 2021, 14 (01)
  • [2] Antiviral Drugs and the Treatment of Hepatitis C
    Ziba Jalali
    Jürgen K. Rockstroh
    Current HIV/AIDS Reports, 2012, 9 : 132 - 138
  • [3] Antiviral Drugs and the Treatment of Hepatitis C
    Jalali, Ziba
    Rockstroh, Juergen K.
    CURRENT HIV/AIDS REPORTS, 2012, 9 (02) : 132 - 138
  • [4] Pharniacokinetics of new oral hepatitis C antiviral drugs
    Vispo, Eugenia
    Barreiro, Pablo
    Soriano, Vicente
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2013, 9 (01) : 5 - 16
  • [5] Cardiotoxicity of treatment hepatitis C by triple combination of antiviral drugs
    Simka, J. Jakub
    Pudil, R.
    Plisek, S.
    EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 : 39 - 39
  • [6] Market uptake of new antiviral drugs for the treatment of hepatitis C
    Lettmeier, Beate
    Muehlberger, Nikolai
    Schwarzer, Ruth
    Sroczynski, Gaby
    Wright, Davene
    Zeuzem, Stefan
    Siebert, Uwe
    JOURNAL OF HEPATOLOGY, 2008, 49 (04) : 528 - 536
  • [7] New antiviral drugs in the treatment of B and C chronic hepatitis
    Peiro, VO
    Viedma, BL
    Cortijo, JC
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 1998, 90 (04) : 291 - 304
  • [8] Development of antiviral drugs for the treatment of hepatitis C at an accelerating pace
    De Clercq, Erik
    REVIEWS IN MEDICAL VIROLOGY, 2015, 25 (04) : 254 - 267
  • [9] Exploratory Study of Oral Combination Antiviral Therapy for Hepatitis C
    Poordad, Fred
    Lawitz, Eric
    Kowdley, Kris V.
    Cohen, Daniel E.
    Podsadecki, Thomas
    Siggelkow, Sara
    Heckaman, Michele
    Larsen, Lois
    Menon, Rajeev
    Koev, Gennadiy
    Tripathi, Rakesh
    Pilot-Matias, Tami
    Bernstein, Barry
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (01): : 45 - 53
  • [10] Pharmaceutical industry payments and prescriptions of direct acting antiviral drugs for hepatitis C virus infection
    Murayama, Anju
    Sigel, Keith M.
    Tarras, Elizabeth S.
    Marshall, Deborah C.
    LIVER INTERNATIONAL, 2024, 44 (12) : 3274 - 3278